Division of Gastroenterology & Hepatology Research | NYU Langone Health

Skip to Main Content

Division of Gastroenterology & Hepatology Research

We conduct research to better care for current and future patients with gastrointestinal and liver conditions.

Our research goals at NYU Langone’s Division of Gastroenterology and Hepatology are to provide access to the latest treatments in the pipeline to our patients and to advance knowledge of gastroenterology and hepatology through innovative basic science, translational research, and clinical trials. We aim to foster a spirit of scientific inquiry and innovation among faculty, fellows, and students.

Our researchers study the biology, prevention, diagnosis, and treatment of gastrointestinal (GI) and liver diseases. Among our current areas of research are the following:

  • role of the gut microbiome in health and the pathogenesis of disease such as colorectal cancer, liver cancer, and fatty liver and other diseases
  • role of GI infection and gut microbial dysbiosis in the pathogenesis of inflammatory bowel disease
  • colorectal cancer prevention, including evaluation of sociodemographic and geographic disparities in colorectal cancer screening and outcomes, the comparative effectiveness of different screening strategies, and novel methods to increase screening adherence
  • quality and innovations in enhanced technologies for colon cancer screening
  • bariatric endoscopy outcomes in obesity and fatty liver disease
  • clinical trials in all areas of liver disease, inflammatory bowel disease, colorectal cancer screening and prevention, and other GI conditions
  • cirrhosis and hepatitis C infection

Select Faculty Publications

IFN-I and IL-22 mediate protective effects of intestinal viral infection

Neil, Jessica A; Matsuzawa-Ishimoto, Yu; Kernbauer-Hölzl, Elisabeth; Schuster, Samantha L; Sota, Stela; Venzon, Mericien; Dallari, Simone; Galvao Neto, Antonio; Hine, Ashley; Hudesman, David; Loke, P'ng; Nice, Timothy J; Cadwell, Ken

Nature microbiology. 2019 Jun 10;

Bending the cost curve: time series analysis of a value transformation programme at an academic medical centre

Chatfield, Steven C; Volpicelli, Frank M; Adler, Nicole M; Kim, Kunhee Lucy; Jones, Simon A; Francois, Fritz; Shah, Paresh C; Press, Robert A; Horwitz, Leora I

BMJ quality & safety. 2019 Jun ; 28:449-458

CLINICAL AND PATIENT-REPORTED OUTCOMES OF TRANSORAL OUTLET REDUCTION (TORE)IN A LARGE URBAN MEDICAL CENTER [Meeting Abstract]

Rolston, V S; Ramprasad, C; DeLatour, R; Goodman, A J; Tzimas, D; Khanna, L G

Gastrointestinal endoscopy. 2019 June; AB280-AB281

DIAGNOSTIC YIELD OF INPATIENT CAPSULE ENDOSCOPY [Meeting Abstract]

Levine, I; Bhakta, D; McNeill, M B; Gross, S A; Latorre, M

Gastrointestinal endoscopy. 2019 June; AB333

EVALUATION OF BOWEL CLEANSING EFFICACY IN HOSPITALIZED PATIENT POPULATION USING THE PURE-VU SYSTEM [Meeting Abstract]

Neumann, H; Latorre, M; Zimmermann, T; Lang, G; Samarasena, J B; Gross, S A; Brahmbhatt, B; Pazwash, H; Kushnir, V

Gastrointestinal endoscopy. 2019 June; AB509

A NOVEL HYBRID TECHNIQUE USING ENDOSCOPIC MUCOSAL RESECTION (EMR)AND ENDOSCOPIC FULL-THICKNESS RESECTION (EFTR)FOR LARGE COLORECTAL NEOPLASMS UNRESECTABLE BY EMR ALONE [Meeting Abstract]

Sofia, Yuen P Y; Vareedayah, A A; Skup, M; Hoerter, N A; Koller, K; Mahadev, S; Haber, G B

Gastrointestinal endoscopy. 2019 June; AB643-AB644

THE HIGH RATE OF BLEEDING WITH DUODENAL POLYPECTOMY MANDATES A STRATEGY SPECIFIC TO THIS LOCATION [Meeting Abstract]

Hoerter, N A; Skup, M; Sofia, Yuen P Y; Vareedayah, A A; Haber, G B

Gastrointestinal endoscopy. 2019 June; AB338

Editorial: bodybuilders beware [Editorial]

Feldman, D M; Jacobson, I M

Alimentary pharmacology & therapeutics. 2019 June; 49:1530